. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: Int J Gynaecol Obstet. 2013 Mar 21;122(1):22–26. doi: 10.1016/j.ijgo.2013.02.013

Table 5.

Adjusted risk of poor neonatal outcomes among infants whose mothers received an injection during delivery

Outcome	Multivariate model ^a			Multivariate model excluding facility births and complicated deliveries ^b

	Total no. of live births	RR	95% CI	Total no. of live births	RR	95% CI
Neonatal respiratory depression	21 512	2.06	1.94–2.19	13 582	2.35	2.18–2.53
Intrapartum-related neonatal respiratory depression	21 512	2.18	2.03–2.33	13 582	2.52	2.29–2.78
Moderate–severe neonatal encephalopathy	20 787	1.27	1.04–1.54	13 183	1.34	1.02–1.76
Intrapartum-related moderate–severe neonatal encephalopathy	20 846	2.92	2.23–3.82	13 246	3.48	2.46–4.93

Abbreviations: CI, confidence interval; RR, relative risk.

Adjusted for sex of child, preterm status, maternal age, parity, maternal and paternal literacy, caste, ethnic group, facility delivery, chlorhexidine receipt status, and complications (prolonged labor, prolonged rupture of membranes, maternal fever, convulsions, or vaginal bleeding).

Adjusted for sex of child, preterm status, maternal age, parity, maternal and paternal literacy, caste, ethnic group, and chlorhexidine receipt status.